Back

The TAB1-p38a complex is a therapeutic target in acute myocardial ischemia: the holy grail of circumstance selective inhibition of p38a.

20 April 2018 (00:00 - 00:00)
Organised by: Logo
Congress Presentation Part of: New strategies for cardioprotection to prevent heart failure Ischaemia, Infarction, Cardioprotection Open Access Frontiers in CardioVascular Biology 2018 Council on Basic Cardiovascular Science

About the speaker

Photo
Doctor Gian Felice De Nicola

King's College London, London (United Kingdom of Great Britain & Northern Ireland)

5 More presentations in this session

Presentation thumbnail
The gut hormone ghrelin in the modulation of cardiac metabolism and vascular resistance
Professor F. Recchia (Pisa, IT)
Slides
Presentation thumbnail
Targeting inflammation for cardioprotection.
Professor S. Lecour (Cape Town, ZA)
Presentation thumbnail
Multi-omics strategies for unbiased identification of novel therapeutic targets for cardioprotection.
Professor P. Ferdinandy (Budapest, HU)
Slides
Presentation thumbnail
Proteomics of cardioprotection.
Professor M. Mayr (London, GB)
Presentation thumbnail
Cardiac-specific overexpression of the transcription factor JunD promotes increased sensitivity to myocardial infarction
Doctor A. Akhmedov (Zurich, CH)
Abstract Slides

Access the full session

Session thumbnail
New strategies for cardioprotection to prevent heart failure

The Event

Event poster

Frontiers in CardioVascular Biology 2018

20 April - 22 April 2018

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources